APA (7th ed.) Citation

Y, R., F, H., A, P., CB, L., GZ, L., JI, J., . . . TE, G. (2017). γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. EMBO molecular medicine, 9(7), 950. https://doi.org/10.15252/emmm.201607265

Chicago Style (17th ed.) Citation

Y, Ran, et al. "γ-Secretase Inhibitors in Cancer Clinical Trials Are Pharmacologically and Functionally Distinct." EMBO Molecular Medicine 9, no. 7 (2017): 950. https://doi.org/10.15252/emmm.201607265.

MLA (9th ed.) Citation

Y, Ran, et al. "γ-Secretase Inhibitors in Cancer Clinical Trials Are Pharmacologically and Functionally Distinct." EMBO Molecular Medicine, vol. 9, no. 7, 2017, p. 950, https://doi.org/10.15252/emmm.201607265.